Clinical Trials

Showing trials with last updates posted in 2023.

NCT04439006 | COMPLETED | PHASE1
10 participants

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-26
Start Date:
2020-10-23
Completion:
2022-09-20
Conditions
  • Aplastic Anemia
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Monoclonal B-Cell Lymphocytosis
  • Monoclonal Gammopathy of Undetermined Significance
  • Myelodysplastic Syndrome
  • Symptomatic COVID-19 Infection Laboratory-Confirmed
Interventions
  • OTHER
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page